Company / Current Assets
Thermo Fisher Scientific Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$28.7B
FY2025
5-year range
$20.1B / $28.7B
FY2021-FY2025
Trend
+29.7%
vs FY2024
Sector context
#10 of 160
Health Care
What the data says
Among 160 Health Care companies, Thermo Fisher Scientific is in the top 6% for current assets. Current Assets returned to growth in FY2025 after 2 years of decline, reaching $28.7B.
Based on SEC 10-K filings.
$28.7B in FY2025 with a 5-year CAGR of +5.5%. Top quartile in the Health Care sector.
Improved from $24.6B to $28.7B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- +5.5%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 160This company $28.7B Sector average $5.2B
▼
+448.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.5%, indicating consistent growth.
- In FY2025, current assets increased 29.7% year-over-year.
- Ranks #10 out of 160 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.7B | +29.7% |
| FY2024 | $22.1B | -10.0% |
| FY2023 | $24.6B | -2.5% |
| FY2022 | $25.2B | +25.4% |
| FY2021 | $20.1B | -8.4% |
| FY2020 | $22.0B | +84.6% |
| FY2019 | $11.9B | +11.9% |
| FY2018 | $10.6B | +12.8% |
| FY2017 | $9.4B | +34.2% |
| FY2016 | $7.0B | +22.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026